As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient.
🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories.
🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation centers, is the largest in Europe, with nearly 80 members and 9 nationalities.
💡 Created in February 2022 at the initiative of the Paris-Saclay University, the Polytechnic Institute of Paris, Inserm, the Gustave Roussy Institute and Sanofi, the PSCC is a continuum of excellence, bringing together research organizations, universities, hospitals, start-ups, scale-ups, industrialists, capital investors, patient associations, government, local authorities, and stakeholders.
Chaired by Professors Eric Vivier and Solange Peters, the association and its Strategic Advisory Board reflect the cluster's twofold ambition: to change the destiny of millions of patients and to position France and Europe at the forefront of the world's leading pharmaceutical industry.
-
Secteur
-
Organisations à but non lucratif
-
Taille de l’entreprise
-
2-10 employés
-
Siège social
-
Villejuif
-
Type
-
Non lucratif
-
Fondée en
-
2022
-
Domaines
-
oncologie, Cancer, Innovation et Oncocluster
